Department of Nephrology and Hypertension, Cleveland Clinic; Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
Medical Director, Cleveland Clinic West Dialysis Unit, Department of Nephrology and Hypertension, Cleveland Clinic; Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH.
Cleve Clin J Med. 2020 Nov 2;87(11):683-694. doi: 10.3949/ccjm.87a.20015.
Concern for contrast-induced acute kidney injury (CI-AKI) or nephrogenic systemic fibrosis may lead to withholding important studies from patients with kidney disease. However, the actual risk or even the existence of these conditions has recently been called into question. The truth probably lies somewhere in the middle.
对对比剂诱导急性肾损伤（CI-AKI）或肾源性系统性纤维化的担忧可能导致某些患有肾脏疾病的患者无法接受重要的研究。然而，这些情况的实际风险甚至其存在最近都受到了质疑。真相可能介于两者之间。
